Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / COMMON STOCK
-
Number of holders
-
35
-
Total 13F shares, excl. options
-
7,317,782
-
Shares change
-
-437,279
-
Total reported value, excl. options
-
$73,712,000
-
Value change
-
+$174,503
-
Number of buys
-
21
-
Number of sells
-
-15
-
Price
-
$10.07
Significant Holders of SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) as of Q4 2014
41 filings reported holding SRNE - SORRENTO THERAPEUTICS INC - COMMON STOCK as of Q4 2014.
SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) has 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7,317,782 shares
.
Largest 10 shareholders include Cormorant Asset Management, LLC (1,750,000 shares), JPMORGAN CHASE & CO (1,135,285 shares), venBio Select Advisor LLC (910,100 shares), VANGUARD GROUP INC (432,210 shares), Talkot Capital, LLC (384,557 shares), BlackRock Institutional Trust Company, N.A. (371,815 shares), BAIRD ROBERT W & CO INC /WI/ (344,273 shares), CAM Group Holding A/S (272,301 shares), DEUTSCHE BANK AG\ (229,195 shares), and Tekla Capital Management LLC (213,896 shares).
This table shows the top 35 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.